Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-16FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) from Cosette Ph…
-
FDA approval · 2015-09-16FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Actavis Pharma, Inc., indicating an approved change to the product labe…
-
FDA approval · 2015-09-16FDA Approved: NADOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Nadolol tablets as a generic drug under an Original Application (ANDA 201893) from Aurobindo Pharma Limited. This approval make…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Rapid Renal Sympathetic Denervation for Resistant Hypertension [NA]
Clinical trial update for rapid renal sympathetic denervation in resistant hypertension; study completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Health Education Using Text Messaging Prevents Hypertension in High Risk People [NA]
A clinical trial update indicates that health education delivered via text messaging may prevent hypertension in high-risk individuals, thou…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes [NA]
Clinical trial NCT01416766, conducted at the University of Massachusetts, Worcester, has completed. The study evaluated an inexpensive infor…
-
FDA approval · 2015-09-14FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for the generic combination drug fosinopril sodium and hydrochlorothiazide (CIPLA USA INC.), expandi…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: The Sympara VIBE Study for Hypertension [Phase 1, Phase 2]
The Sympara VIBE Study for Hypertension, a Phase 1/Phase 2 trial sponsored by Sympara Medical, Inc., has been terminated. No clinical result…
-
FDA approval · 2015-09-10FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Improving Outcomes for Hypertensive Children
This document reports a completed clinical trial update from Arkansas Children's Hospital Research Institute related to outcomes in pediatri…
-
CLINICAL_TRIALS withdrawal · 2015-09-09Clinical Trial Update: Effect of Stevioside in Postpandrial Glucose in Healthy Adults [NA]
A clinical trial studying the effect of stevioside on postprandial glucose in healthy adults has been withdrawn.
-
FDA approval · 2015-09-08FDA Approved: NIFEDIPINE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for nifedipine (ANDA075289), authorizing a modification to the approved gen…
-
FDA approval · 2015-09-08FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Metoprolol Tartrate from Aurobindo Pharma Limited, a generic beta-blocker used in cardiovascular…
-
FDA approval · 2015-09-08FDA Approved: TELMISARTAN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves the original application for telmisartan (generic) from Amneal Pharmaceuticals of New York LLC. Telmisartan is used to treat hy…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients [Phase 3]
Phase 3 trial data assess safety, tolerability, and efficacy of LCZ696 (sacubitril/valsartan) in Japanese patients with severe hypertension;…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Antihypertensive Treatment in Acute Cerebral Hemorrhage [Phase 1]
Phase 1 trial update reports completed results for an antihypertensive treatment studied in acute intracerebral hemorrhage. The study focuse…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Cardiovascular Disease Risk Factors in Chinese American Immigrants
A completed clinical trial assessing cardiovascular disease risk factors in Chinese American immigrants with hypertension and related metabo…
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes [Phase 4]
A completed Phase 4 trial comparing telmisartan and valsartan on neointima volume in diabetes was conducted.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients [NA]
This clinical trial update examines the effects of telmisartan on ischemic cardiovascular events in high-risk hypertensive patients, with th…
-
FDA approval · 2015-09-03FDA Approved: TELMISARTAN — Original Application (Aurobindo Pharma Limited)
FDA approves the original application for telmisartan from Aurobindo Pharma Limited, a generic ARB for hypertension. The approval permits ma…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: LEPU Renal Denervation System for Resistant Hypertension [Phase 3]
A Phase 3 clinical trial evaluating the LEPU Renal Denervation System for resistant hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: OneShot Renal Denervation Registry [Phase 2, Phase 3]
This document reports the termination of the OneShot Renal Denervation Registry trial (Phase 2/3). It was sponsored by Medtronic Endovascula…
-
FDA approval · 2015-09-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease [Phase 2, Phase 3]
This clinical trial update reports the completion and posting of results for a Phase 2/3 study evaluating the diagnosis and treatment of obs…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Effect of Febuxostat on Blood Pressure [Phase 2]
Phase 2 clinical trial update evaluating the effect of febuxostat on blood pressure in hypertension; results have been posted.